About Astex Pharmaceuticals
Astex Pharmaceuticals is a company based in Pleasanton (United States) founded in 1991 was acquired by Otsuka in September 2013.. Astex Pharmaceuticals has raised $3 million across 2 funding rounds from investors including Otsuka, SuperGen and NEA. The company has 115 employees as of December 31, 2022. Astex Pharmaceuticals offers products and services including Kisqali, Balversa, Truqap, and Tolinapant. Astex Pharmaceuticals operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others.
- Headquarter Pleasanton, United States
- Employees 115 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Astex Pharmaceuticals
Astex Pharmaceuticals offers a comprehensive portfolio of products and services, including Kisqali, Balversa, Truqap, and Tolinapant. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
CDK4/6 inhibitor for oncology treatment in solid tumors.
FGFr inhibitor targeting oncology in solid tumors.
PKB/Akt inhibitor for oncology applications.
Dual IAP antagonist for T-cell lymphomas treatment.
Unlock access to complete
Funding Insights of Astex Pharmaceuticals
Astex Pharmaceuticals has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $3.0M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2009 | Amount | Series A - Astex Pharmaceuticals | Valuation |
investors |
|
| Jun, 2008 | Amount | Unspecified - Astex Pharmaceuticals | Valuation | New Enterprise Associates |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Astex Pharmaceuticals
Astex Pharmaceuticals has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Otsuka, SuperGen and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Generic pharmaceuticals and nutraceuticals are manufactured and marketed by Otsuka.
|
Founded Year | Domain | Location | |
|
Cancer therapeutics targeting epigenetic mechanisms are developed for oncology applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Astex Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Astex Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Astex Pharmaceuticals Comparisons
Competitors of Astex Pharmaceuticals
Astex Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Astex Pharmaceuticals
Frequently Asked Questions about Astex Pharmaceuticals
When was Astex Pharmaceuticals founded?
Astex Pharmaceuticals was founded in 1991 and raised its 1st funding round 17 years after it was founded.
Where is Astex Pharmaceuticals located?
Astex Pharmaceuticals is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Who is the current CEO of Astex Pharmaceuticals?
Harren Jhoti is the current CEO of Astex Pharmaceuticals.
Is Astex Pharmaceuticals a funded company?
Astex Pharmaceuticals is a funded company, having raised a total of $3M across 2 funding rounds to date.
How many employees does Astex Pharmaceuticals have?
As of Dec 31, 2022, the latest employee count at Astex Pharmaceuticals is 115.
What does Astex Pharmaceuticals do?
Astex Pharmaceuticals is focused on drug discovery and development with focus on cancer and CNS disorders. Pipeline products at various stages of clinical trials include Guadecitabine (a DNA methyltransferase inhibitor) for naive and refractory AML, solid tumors and hematologic malignancies, (Phase 3 trials), onalespib for lung and melanoma, AT7519 for solid tumors, AT13148 for solid tumors, ASTX727 for myelodysplastic syndrome (MDS) and ASTX660 for solid tumors etc among other partner products. Company got acquired by Otsuka pharmaceuticals in 2013 and now operates as a wholly owned subsidiary.
Who are the top competitors of Astex Pharmaceuticals?
Astex Pharmaceuticals's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Astex Pharmaceuticals offer?
Astex Pharmaceuticals offers Kisqali, Balversa, Truqap, and Tolinapant.